Overexpression of β2AR improves contractile function and cellular survival in rabbit cardiomyocytes under chronic hypoxia

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 383-388

  Dong, Hongyan ^a   Chen, Qiang ^a   Sun, Shengli ^a   Yu, Hongli ^a   Zhang, Zhongming ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

2 Adrenergic receptor; Cardiomyocyte; Chronic hypoxia; Contractile function; Gene transfer

Indexed keywords

ADENOVIRUS VECTOR; BETA 2 ADRENERGIC RECEPTOR; CASPASE 3; CATECHOLAMINE; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RECOMBINANT ADV HUMAN BETA2 ADRENERGIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYANOTIC HEART DISEASE; DIASTOLE; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; HYPOXIA; INOTROPISM; NONHUMAN; PRIORITY JOURNAL; RABBIT; SYSTOLE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; ANOXIA; CELL SURVIVAL; CYANOSIS; DISEASE MODELS, ANIMAL; GENE THERAPY; HEART DEFECTS, CONGENITAL; HUMANS; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RABBITS; RECEPTORS, ADRENERGIC, BETA-2;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 77955272186     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.076     Document Type: Article

References (26)

1. Dzimiri N., Galal O., Moorji A., et al. Regulation of sympathetic activity in children with various congenital heart diseases. Pediatr. Res. 1995, 38:55-60.
2. Najm H.K., Wallen W.J., Belanger M.P., et al. Dose the degree of cyanosis affect myocardial adenosine triphosphate levels and function in children undergoing surgical procedures for congenital heart disease?. J. Thorac. Cardiovasc. Surg. 2000, 119:515-524.
3. Kozlik R., Kramer H.H., Wicht H., et al. Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease. Eur. J. Pediatr. 1991, 150:388-394.
4. Chowdhury U.K., Sathia S., Ray R., et al. Histopathology of the right ventricular outflow tract and its relationship to clinical outcomes and arrhythmias in patients with tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 2006, 132:270-277.
5. Milano C.A., Allen L.F., Rockman H.A., et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994, 264:582-586.
6. 2-Adrenergic receptors potentiates the functional recovery of unloaded failing hearts. Circulation 2002, 106:124-129.
7. Patterson A.J., Zhu W., Chow A., et al. Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart. Crit. Care Med. 2004, 32:1041-1048.
8. Chesley A., Lundberg M.S., Asai T., et al. The beta (2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. Circ. Res. 2000, 87:1172-1179.
9. Liggett S.B., Tepe N.M., Lorenz J.N., et al. Early and delayed consequences of beta (2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 2000, 101:1707-1714.
10. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
11. Gong H., Sun H., Koch W.J., et al. Specific ß2AR blocker ICI 118, 551 actively decreases contraction through a Gi-coupled form of the ß2AR in myocytes from failing human heart. Circulation 2002, 105:2497-2503.
12. 4-adrenoceptor pharmacology. Br. J. Pharmacol. 2004, 141:813-824.
13. Pei J.M., Wang Y.M., Ma H. β-adrenoceptor desensitization and changes of calcium transient in rat ventricular myocytes following chronic hypoxia. Chin. J. Pathophysiol. 2003, 19:455-459.
14. 2+ dynamics, contractility, or phospholamban phosphorylation. J. Biol. Chem. 1994, 269:19151-19156.
15. Zaugg M., Xu W., Lucchinetti E., et al. Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 2000, 102:344-350.
16. Communal C., Singh K., Douglas B., et al. Opposing effects of ß1- and ß2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 1999, 100:2210-2212.
17. Li J., Bombeck C.A., Yang S. Nitric oxide suppresses apoptosis via interrupting Caspase activation and mitochondrial dysfunction in cultured hepatocytes. J. Biol. Chem. 1999, 274:17325-17333.
18. Lefkowitz R.J., Rockman H.A., Koch W.J. Catecholamines, cardiac β-adrenergic receptors, and heart failure. Circulation 2000, 101:1634-1637.
19. Communal C., Colucci W.S. The control of cardiomyocyte apoptosis via the beta-adrenergic signalling pathways. Arch. Mal. Coeur Vaiss. 2005, 98:236-241.
20. Basu A., Tu H. Activation. ERK during DNA damage-induced apoptosis involves protein kinase C delta. Biochem. Biophys. Res. Commun. 2005, 334:1068-1073.
21. Zhu W.Z., Zheng M., Koch W.J., et al. Dual modulation of cell survival and cell death by beta (2)-adrenergic signalling in adult mouse cardiac myocytes. PNAS 2001, 98:1607-1612.
22. Day S.M., Westfall M.V., Metzger J.M. Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. Mol. Med. 2007, 85:911-921.
23. Narolska N.A., Piroddi N., Belus A., et al. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ. Res. 2006, 99:1012-1020.
24. Messer A.E., Jacques A.M., Marston S.B. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J. Mol. Cell. Cardiol. 2007, 2:247-259.
25. Bilchick K.C., Duncan J.G., Ravi R., et al. Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H318-H325.
26. Jonesa J.M., Wilsonb K.H., Kocha W.J., et al. Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression. Eur. J. Cardiothorac. Surg. 2002, 21:847-852.